Hoffman Michael B
SEC-identified person · CIK 1290208 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Translational Development Acquisition Corp. TDAC | Director · Chief Executive Officer | filed 2024–2026 |
| Annovis Bio, Inc. ANVS | Director | filed 2020–2026 |
| Northern Genesis Acquisition Corp. III NGC.U | President | filed 2021–2021 |
| Northern Genesis Acquisition Corp. II NGAB.U | President | filed 2021–2021 |
| Traws Pharma, Inc. TRAW | Director | filed 2013–2020 |
| Northern Genesis Acquisition Corp. NGA.U | President | filed 2020–2020 |
| Talen Energy Corp TLN | Director | filed 2015–2015 |
| Enviva, LLC NYSE | Director | filed 2015–2015 |
| Pattern Energy Group Inc. PEGI | Director | filed 2013–2013 |
| Buckeye Partners, L.P. bpl | Director | filed 2006–2006 |
| Buckeye GP Holdings L.P. BGH | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.